WEINSTEIN ROBERT
Transaction: 06/18/2026
OTHER
Change
0
Price
Not reported
Filing
06/25/2026
Type
OTHER
Petros Pharmaceuticals, Inc.
PTPI • Drug Manufacturers - Specialty & Generic
Extraordinary move
PTPI+20.00%
vs. previous close $0.01
$0.01
▲ +0.00 (+20.00%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$284,350.398
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Reasonable earnings multiple · 1.17Manageable debt level · 0Healthy liquidity · 2.25Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:43 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.01
Change20.00%
Shares Out47.39M
Market Cap$284.35K
Enterprise Value$-3.20M
52W Range0.00 - 0.03
Beta1.92
P/E-0.09
P/B0.41
P/FCF-0.08
EV/EBITDA1.24
EV/FCF0.86
Price$0.01
Change20.00%
Shares Out47.39M
Market Cap$284.35K
Enterprise Value$-3.20M
52W Range0.00 - 0.03
Beta1.92
P/E-0.09
P/B0.41
P/FCF-0.08
EV/EBITDA1.24
EV/FCF0.86
Dividend Yield83.33%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio2.25
Quick Ratio2.25
Revenue 5Y-100.00%
Volume32.28K
Avg Volume107.89K
EPS Surprise-20.75
Investment DNA
How strong this company looks for long-term investors
37
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Reasonable earnings multiple · 1.17Manageable debt level · 0Healthy liquidity · 2.25Negative growth trendWeak profitability
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
WALKER WAYNE REMELL
Transaction: 06/05/2026
BUY
Change
+375,000
Price
Not reported
Filing
06/08/2026
Type
BUY
Silverman Joshua
Transaction: 06/05/2026
BUY
Change
+4,375,000
Price
Not reported
Filing
06/05/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| WEINSTEIN ROBERT | OTHER | 0 | Not reported | 06/18/2026 | 06/25/2026 |
| WALKER WAYNE REMELL | BUY | +375,000 | Not reported | 06/05/2026 | 06/08/2026 |
| Silverman Joshua | BUY | +4,375,000 | Not reported | 06/05/2026 | 06/05/2026 |
| Bernstein Bruce | BUY | +1,875,000 | Not reported | 06/05/2026 | 06/05/2026 |
| Boctor Fady | BUY | +375,000 | Not reported | 06/05/2026 | 06/05/2026 |
| Boctor Fady | BUY | +500,000 | Not reported | 01/02/2026 | 01/06/2026 |
| Bernstein Bruce | BUY | +1,875,000 | Not reported | 01/02/2026 | 01/02/2026 |
| WALKER WAYNE REMELL | BUY | +500,000 | Not reported | 01/02/2026 | 01/02/2026 |
| Silverman Joshua | BUY | +4,375,000 | Not reported | 01/02/2026 | 01/02/2026 |
| Bernstein Bruce | BUY | +300,000 | Not reported | 02/19/2025 | 02/21/2025 |
| Boctor Fady | BUY | +450,000 | Not reported | 02/19/2025 | 02/21/2025 |
| Silverman Joshua | BUY | +1,000,000 | Not reported | 02/19/2025 | 02/21/2025 |
| Arnold Mitchell | BUY | +150,000 | Not reported | 02/19/2025 | 02/21/2025 |
| WALKER WAYNE REMELL | BUY | +150,000 | Not reported | 02/19/2025 | 02/21/2025 |
| Bradley Greg | BUY | +40,000 | $1.41 | 12/21/2023 | 12/26/2023 |
| Silverman Joshua | BUY | +40,000 | $1.41 | 12/21/2023 | 12/26/2023 |
| Arnold Mitchell | BUY | +20,000 | $1.41 | 12/21/2023 | 12/26/2023 |
| WALKER WAYNE REMELL | BUY | +40,000 | $1.41 | 12/21/2023 | 12/26/2023 |
| Boctor Fady | BUY | +49,645 | Not reported | 12/21/2023 | 12/26/2023 |
| Boctor Fady | BUY | +54,533 | $1.41 | 12/21/2023 | 12/26/2023 |